Abciximab in the treatment of acute myocardial infarction eligible for primary percutaneous transluminal coronary angioplasty. Results of the Glycoprotein Receptor Antagonist Patency Evaluation (GRAPE) pilot study

Journal of the American College of Cardiology

Volumn 33, Issue 6, 1999, Pages 1528-1532

  Van den Merkhof, Lambert F M ^a   Zijlstra, Felix ^b   Olsson, Hans ^c   Grip, Lars ^d   Veen, Gerrit ^e   Bär, Frits W H M ^f   Van den Brand, Marcel J B M ^g   Simoons, Maarten L ^g   Verheugt, Freek W A ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b HOSPITAL DE WEEZENLANDEN   (Netherlands)

^c ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^d SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^e VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^f MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^g ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; FIBRINOGEN RECEPTOR;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CORONARY ARTERY BLOOD FLOW; DRUG EFFECT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT INDICATION;

ADULT; AGED; AGED, 80 AND OVER; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTIBODIES, MONOCLONAL; ASPIRIN; CORONARY CIRCULATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; HEPARIN; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PILOT PROJECTS; PLATELET AGGREGATION INHIBITORS; PREMEDICATION;

EID: 0033133399     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(99)00038-8     Document Type: Article

References (24)

1. Simoons M.L., Van den Brand M., De Zwaan C., et al. Improved survival after early thrombolysis in acute myocardial infarction. A randomised trial by the Interuniversity Cardiology Institute in the Netherlands. Lancet. 2:1985;578-581.
2. GUSTO Investigators . An international randomised trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med. 329:1993;673-682.
3. GUSTO Angiographic Investigators . The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. N Engl J Med. 22:1993;1615-1622.
4. Grines C.L., Browne K.F., Marco J., et al. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. N Engl J Med. 328:1993;673-679.
5. Zijlstra F., De Boer M.J., Hoorntje J.C.A., et al. A comparison of immediate angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med. 328:1993;680-684.
6. Weaver W.D., Simes R.J., Betriu A., et al. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction a quantitative review . JAMA. 278:1997;2093-2098.
7. TIMI Study Group . Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) phase II trial. New Engl J Med. 320:1989;618-627.
8. Verheugt F.W.A., Marsh R.C., Veen G., Liem A., Zijlstra F. High-dose bolus heparin as initial therapy prior to primary angioplasty for acute myocardial infarction results of the HEAP pilot study . J Am Coll Cardiol. 31:1998;289-293.
9. Braga J.C., Esteves F.P., Esteves J.P., et al. Confirmation that heparin is an alternative means of promoting early reperfusion. Coron Artery Dis. 9:1998;335-338.
10. CAPTURE investigators . Randomised placebo-controlled trial of abciximab before, during and after coronary intervention in refractory unstable angina the CAPTURE study . Lancet. 349:1997;1429-1435.
11. PRISM-PLUS Study Investigators . Inhibition of platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q wave myocardial infarction. N Engl J Med. 338:1998;1488-1497.
12. PARAGON Investigators . An international, randomised, controlled trial of lamifiban, a platelet glycoprotein IIb/IIIa inhibitor or heparin or both in unstable angina. Circulation. 97:1998;2386-2395.
13. PURSUIT Investigators . Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes. N Engl J Med. 339:1998;436-443.
14. PRISM Study Investigators . A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina. N Engl J Med. 338:1998;1498-1505.
15. Gold H.K., Garabedian H.D., Dinsmore R.E., et al. Restoration of coronary flow in myocardial infarction by intravenous chimeric 7E3 antibody without exogenous plasminogen activators observations in animals and humans . Circulation. 95:1997;1755-1759.
16. Chesebro J.H., Knatterud G., Roberts R., et al. Thrombolysis in myocardial infarction (TIMI) trial, phase I a comparison between intravenous tissue plasminogen activator and intravenous streptokinase . Circulation. 76:1987;142-154.
17. GUSTO-IIb Angioplasty Substudy Investigators . A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction. N Engl J Med. 336:1997;1621-1628.
18. Ohman EM. Results of the SPEED (Strategies for Patency Enhancement in the Emergency Department) study. Presented at the 47th Scientific Session American College of Cardiology, Atlanta, March 1998.
19. Antman EM. Results of the TIMI-14A trial. Presented at the 47th Scientific Session American College of Cardiology, Atlanta, March 1998.
20. Davies M.J., Thomas A.C. Plaque fissuring - the cause of acute myocardial infarction, sudden death, and crescendo angina. Br Heart J. 53:1985;363-373.
21. Falk E., Shah P.K., Fuster V. Coronary plaque disruption. Circulation. 92:1995;657-671.
22. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group . Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction ISIS-2 . Lancet. 2:1988;349-360.
23. Mahdi N.A., Leinbach R., Dinsmore R.E., Newell J., Gold H.K. Predictors of coronary reflow with intravenous chimeric 7E3 antibody in acute myocardial infarction (abstr). J Am Coll Cardiol. 31:(Suppl A):1998;230A.
24. Brener S.J., Barr L.A., Burchenal J.E.B., et al. Randomized, placebo-controlled trial of platelet glycoprotein IIb/IIIa blockade with primary angioplasty for acute myocardial infarction. Circulation. 98:1998;734-741.